Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML
Although NPM1-mutated acute myeloid leukemia (AML) carries a generally favorable
prognosis, many patients still relapse and die. Previous studies identified several molecular …
prognosis, many patients still relapse and die. Previous studies identified several molecular …